Research Reports
We recently teamed up with the researchers at Datamonitor to provide the Fierce community with access to the latest in paid Life Science industry intelligence. You can search for in-depth pipeline reports, competitor profiles, analysis of key trends and more at the following links:
Life Science Analytics Reporting Center
Datamonitor Report Center
We have also hand selected some reports that you may find of interest. You can see them below:
Life Science Analytics Reporting Center
Datamonitor Report Center
We have also hand selected some reports that you may find of interest. You can see them below:
Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
Date Published:
28-April-08 Price:
$3,800 Source:
Datamonitor While drug eluting stents have been successful in reducing the rate of restenosis following percutaneous coronary intervention, there have been safety scares over a new problem: “in-stent thrombosis”. Opinion leaders are divided over the gravity of this problem, but positive safety data are required to restore physician confidence in drug eluting stents.
Impact of Pharmacogenomics on Public Healthcare Policy
Date Published:
March 08 Price:
$3,835.00 Source:
Business Insights In the 21st Century there is a growing trend towards the development of personalized medicine – the right drug for the right individual. Examine the rapidly advancing fields of pharmacogenomics and pharmacogenetics, and measure the impact of pharmacogenomic techniques on reimbursement and health economics with this new report.
The Cardiovascular Disorders Market Outlook to 2012
Date Published:
Feb-08 Price:
$3,835 Source:
Business Insights The Cardiovascular Disorders Market Outlook to 2012 is a new report published by Business Insights that provides comprehensive coverage of every class of drugs across all major cardiovascular indications. Detailed insights into recent key events and future market leaders are also provided, in addition to epidemiological analysis and forecasts for major products over the period 2007-12.
2008 Trends to Watch: Pharmaceutical Technology
Date Published:
31-Jan-08 Price:
$1,895 Source:
Datamonitor An overview of the challenges facing the life science industry in 2008 Datamonitor's take on the technology priorities of pharmaceutical and biotechnology companies Strategies to help technology vendors penetrate the life science industry.
Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Price:
$2,875.00 Source:
Datamonitor Use this report to develop effective pricing strategies based upon this report’s unique market forecasts for future pricing scenarios in key markets and understand the major issues affecting the global pricing landscape.
Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Date Published:
January 9, 2008 Price:
$15,200.00 Source:
Datamonitor Declining growth rates in developed markets mean many pharmaceutical companies are turning their attention to developing markets.
Generics Series: Key trends and events in the 7 major markets
Date Published:
December 19, 2007 Price:
$3,800.00 Source:
Datamonitor Use this report to gain an understanding of the major drivers and resistors to generic growth in each of the 7 major markets.
Examining the Global Market for Electronic Health Records (Market Focus)
Date Published:
September 2007 Price:
$1,895 Source:
Datamonitor Electronic health records (EHRs) will be the cornerstone of healthcare technology. The design, selection and implementation of EHRs, therefore, will be extremely important for healthcare institutions.
Innovations in Cardiovascular Disease Management: Latest surgical procedures, drugs and medical devices
Date Published:
September 2007 Price:
$2,875 Source:
Business Insights Report This report will analyse the future potential of new and emerging products from the medical device, pharmaceutical and biotechnology sectors, and measure their likely impact upon the existing market.
Disease Management and Drug Adherence: Strategies to support patients and enhance treatment persistence
Date Published:
July 2007 Price:
$7,600 Source:
Datamonitor The medical establishment's approach to adherence is changing as it becomes clear that the responsibility of achieving adherence is not solely the patient's, but rather is shared among stakeholders. Learn how communication between patients, physicians and the pharmaceutical industry impacts rates of adherence.




